{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,25]],"date-time":"2026-04-25T13:57:09Z","timestamp":1777125429960,"version":"3.51.4"},"reference-count":41,"publisher":"Wiley","issue":"3","license":[{"start":{"date-parts":[[2010,2,24]],"date-time":"2010-02-24T00:00:00Z","timestamp":1266969600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Int J Immunogenetics"],"published-print":{"date-parts":[[2010,6]]},"abstract":"<jats:title>Summary<\/jats:title><jats:p>Natural killer (NK) cells eliminate infected and transformed cells while still are self\u2010tolerant. Interactions of the independently segregating Killer cell immunoglobulin\u2010like receptors (<jats:italic>KIR<\/jats:italic>) and human leucocyte antigens (<jats:italic>HLA<\/jats:italic>) loci play a critical role in NK cell regulation. Different compound <jats:italic>KIR\u2010HLA<\/jats:italic> genotypes can impart different thresholds of activation to the NK\u2010cell repertoire and such genotypic variation has been found to confer altered risk in a number of human diseases including viral infections, autoimmune disorders, reproduction abnormalities and cancers. In this study, we presented a novel combined <jats:italic>KIR\u2010HLA<\/jats:italic> polymerase chain reaction\u2013sequence\u2010specific primers genotyping assay for simultaneous determination of <jats:italic>KIR<\/jats:italic> genes and their three major <jats:italic>HLA class I ligand<\/jats:italic> groups (<jats:italic>C1<\/jats:italic>, <jats:italic>C2<\/jats:italic>, and <jats:italic>Bw4<\/jats:italic>). Moreover, known inhibitory and activating <jats:italic>KIR\u2003+\u2003HLA<\/jats:italic> (<jats:italic>iKIR\u2003+\u2003HLA<\/jats:italic>: <jats:italic>2DL2\/3\u2003+\u2003C1<\/jats:italic>, <jats:italic>2DL1\u2003+\u2003C2<\/jats:italic>, <jats:italic>3DL1\u2003+\u2003Bw4<\/jats:italic>; and <jats:italic>aKIR\u2003+\u2003HLA<\/jats:italic>: <jats:italic>2DS2\u2003+\u2003C1<\/jats:italic>, <jats:italic>2DS1\u2003+\u2003C2<\/jats:italic>, <jats:italic>3DS1\u2003+\u2003Bw4<\/jats:italic>) combinations as well as co\u2010inheritance of <jats:italic>aKIR<\/jats:italic> genes and <jats:italic>iKIR\u2003+\u2003HLA<\/jats:italic> pairs were analysed in a total of 200 unrelated healthy Iranian individuals. All tested subjects had at least one of the three <jats:italic>iKIR\u2003+\u2003HLA<\/jats:italic> pairs and the frequencies of various inhibitory combinations in the study group were: 31.5%, three <jats:italic>iKIR\u2003+\u2003HLA<\/jats:italic> pairs, 53.5%, two <jats:italic>iKIR\u2003+\u2003HLA<\/jats:italic> pairs, and 15%, 0ne <jats:italic>iKIR\u2003+\u2003HLA<\/jats:italic> pair. Furthermore, we revealed that majority of Iranians (69%) carry compound genotypes with greater number of inhibitory pairings than activating combinations (<jats:italic>iKIR\u2003+\u2003HLA\u2003<\/jats:italic>&gt;\u2003<jats:italic>aKIR\u2003+\u2003HLA<\/jats:italic>). Conversely, <jats:italic>iKIR\u2003+ HLA\u2003<\/jats:italic>&lt;\u2003<jats:italic>aKIR<\/jats:italic> (45%) was dominant genotype in the study group. We conclude that selective evolutionary pressure has propensity to maintain <jats:italic>KIR\u2010HLA<\/jats:italic> genotypes with more inhibitory combinations to guarantee self\u2010tolerance. In contrast, existence of activating <jats:italic>KIR<\/jats:italic> genes without normal endogenous ligands, potentially arms the NK population for competent immunosurveillance and stronger defense against infections.<\/jats:p>","DOI":"10.1111\/j.1744-313x.2010.00906.x","type":"journal-article","created":{"date-parts":[[2010,2,25]],"date-time":"2010-02-25T04:34:56Z","timestamp":1267072496000},"page":"159-168","source":"Crossref","is-referenced-by-count":51,"title":["Compound <i>KIR<\/i>\u2010<i>HLA<\/i> genotype analyses in the Iranian population by a novel PCR\u2013SSP assay"],"prefix":"10.1111","volume":"37","author":[{"given":"N.","family":"Tajik","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"Shahsavar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Nasiri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M. F.","family":"Radjabzadeh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2010,5,19]]},"reference":[{"key":"e_1_2_6_2_1","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20070695"},{"key":"e_1_2_6_3_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00251-009-0378-7"},{"key":"e_1_2_6_4_1","doi-asserted-by":"publisher","DOI":"10.1002\/eji.1830271203"},{"key":"e_1_2_6_5_1","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.175.8.5222"},{"key":"e_1_2_6_6_1","volume-title":"The KIR Gene Cluster","author":"Carrington M.","year":"2003"},{"key":"e_1_2_6_7_1","doi-asserted-by":"publisher","DOI":"10.1084\/jem.180.4.1235"},{"key":"e_1_2_6_8_1","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.179.2.854"},{"key":"e_1_2_6_9_1","doi-asserted-by":"crossref","first-page":"3098","DOI":"10.4049\/jimmunol.156.9.3098","article-title":"A human killer inhibitory receptor specific for HLA\u2010A1, 2","volume":"156","author":"Dohring C.","year":"1996","journal-title":"Journal of Immunology"},{"key":"e_1_2_6_10_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00251-006-0168-4"},{"key":"e_1_2_6_11_1","doi-asserted-by":"publisher","DOI":"10.1093\/intimm\/dxn013"},{"key":"e_1_2_6_12_1","doi-asserted-by":"publisher","DOI":"10.3109\/08916938809010684"},{"key":"e_1_2_6_13_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0198-8859(02)00373-7"},{"key":"e_1_2_6_14_1","doi-asserted-by":"publisher","DOI":"10.1084\/jem.181.3.1133"},{"key":"e_1_2_6_15_1","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.158.11.5237"},{"key":"e_1_2_6_16_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.coi.2004.11.001"},{"key":"e_1_2_6_17_1","doi-asserted-by":"publisher","DOI":"10.1172\/JCI116000"},{"key":"e_1_2_6_18_1","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.169.9.5118"},{"key":"e_1_2_6_19_1","doi-asserted-by":"publisher","DOI":"10.1038\/319675a0"},{"key":"e_1_2_6_20_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0198-8859(02)00413-5"},{"key":"e_1_2_6_21_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.1097670"},{"key":"e_1_2_6_22_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.smim.2008.06.003"},{"key":"e_1_2_6_23_1","doi-asserted-by":"publisher","DOI":"10.1016\/0167-5699(90)90097-S"},{"key":"e_1_2_6_24_1","doi-asserted-by":"publisher","DOI":"10.1038\/ng934"},{"key":"e_1_2_6_25_1","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.171.5.2192"},{"key":"e_1_2_6_26_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.gene.2004.03.018"},{"key":"e_1_2_6_27_1","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/16.3.1215"},{"key":"e_1_2_6_28_1","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.180.6.3969"},{"key":"e_1_2_6_29_1","doi-asserted-by":"publisher","DOI":"10.1084\/jem.171.3.695"},{"key":"e_1_2_6_30_1","doi-asserted-by":"publisher","DOI":"10.1038\/nri1570"},{"key":"e_1_2_6_31_1","doi-asserted-by":"publisher","DOI":"10.1084\/jem.189.7.1093"},{"key":"e_1_2_6_32_1","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.168.5.2307"},{"key":"e_1_2_6_33_1","doi-asserted-by":"publisher","DOI":"10.1038\/ng2077"},{"key":"e_1_2_6_34_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0503594102"},{"key":"e_1_2_6_35_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1399-0039.2009.01263.x"},{"key":"e_1_2_6_36_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1074-7613(01)00197-2"},{"key":"e_1_2_6_37_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00251-002-0463-7"},{"key":"e_1_2_6_38_1","doi-asserted-by":"publisher","DOI":"10.2337\/diabetes.52.10.2639"},{"key":"e_1_2_6_39_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1399-0039.2007.00923.x"},{"key":"e_1_2_6_40_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.080588597"},{"key":"e_1_2_6_41_1","doi-asserted-by":"crossref","first-page":"4026","DOI":"10.4049\/jimmunol.158.9.4026","article-title":"A single amino acid in the p58 killer cell inhibitory receptor controls the ability of natural killer cells to discriminate between the two groups of HLA\u2010C allotypes","volume":"158","author":"Winter C.C.","year":"1997","journal-title":"Journal of Immunology"},{"key":"e_1_2_6_42_1","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.161.2.571"}],"container-title":["International Journal of Immunogenetics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1744-313X.2010.00906.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1744-313X.2010.00906.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,15]],"date-time":"2023-10-15T19:56:56Z","timestamp":1697399816000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1744-313X.2010.00906.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,5,19]]},"references-count":41,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2010,6]]}},"alternative-id":["10.1111\/j.1744-313X.2010.00906.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1744-313x.2010.00906.x","archive":["Portico"],"relation":{},"ISSN":["1744-3121","1744-313X"],"issn-type":[{"value":"1744-3121","type":"print"},{"value":"1744-313X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,5,19]]}}}